STRATA Skin Sciences, Inc. (SSKN)
USD 2.59
(-1.19%)
USD 2.59
(-1.19%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 15.04 Million USD | 86.05% |
| 2022 | 8.08 Million USD | 4.86% |
| 2021 | 7.71 Million USD | 338.13% |
| 2020 | 1.76 Million USD | 63.27% |
| 2019 | 1.07 Million USD | -84.91% |
| 2018 | 7.14 Million USD | -9.02% |
| 2017 | 7.85 Million USD | -63.94% |
| 2016 | 21.78 Million USD | 2.34% |
| 2015 | 21.28 Million USD | 325.55% |
| 2014 | 5 Million USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 15.11 Million USD | 0.26% |
| 2024 Q1 | 15.07 Million USD | 0.21% |
| 2023 FY | 15.04 Million USD | 86.05% |
| 2023 Q1 | 8 Million USD | -0.99% |
| 2023 Q3 | 15.29 Million USD | -0.49% |
| 2023 Q2 | 15.37 Million USD | 92.03% |
| 2023 Q4 | 15.04 Million USD | -1.66% |
| 2022 Q4 | 8.08 Million USD | -0.28% |
| 2022 Q3 | 8.1 Million USD | 5.53% |
| 2022 FY | 8.08 Million USD | 4.86% |
| 2022 Q1 | 7.68 Million USD | -0.4% |
| 2022 Q2 | 7.68 Million USD | 0.05% |
| 2021 Q4 | 7.71 Million USD | -0.21% |
| 2021 Q1 | 1.33 Million USD | -24.43% |
| 2021 Q2 | 1.01 Million USD | -24.06% |
| 2021 Q3 | 7.72 Million USD | 665.05% |
| 2021 FY | 7.71 Million USD | 338.13% |
| 2020 Q4 | 1.76 Million USD | -19.93% |
| 2020 Q3 | 2.19 Million USD | -16.27% |
| 2020 Q2 | 2.62 Million USD | 165.69% |
| 2020 Q1 | 988 Thousand USD | -8.35% |
| 2020 FY | 1.76 Million USD | 63.27% |
| 2019 Q1 | 6.9 Million USD | -3.43% |
| 2019 Q3 | 6.14 Million USD | -11.79% |
| 2019 Q4 | 1.07 Million USD | -82.46% |
| 2019 FY | 1.07 Million USD | -84.91% |
| 2019 Q2 | 6.96 Million USD | 0.96% |
| 2018 Q2 | 7.37 Million USD | 7.32% |
| 2018 Q1 | 6.86 Million USD | -12.53% |
| 2018 Q4 | 7.14 Million USD | -2.95% |
| 2018 FY | 7.14 Million USD | -9.02% |
| 2018 Q3 | 7.36 Million USD | -0.14% |
| 2017 FY | 7.85 Million USD | -63.94% |
| 2017 Q1 | 21.64 Million USD | -0.63% |
| 2017 Q2 | 21.53 Million USD | -0.49% |
| 2017 Q3 | 8.84 Million USD | -58.94% |
| 2017 Q4 | 7.85 Million USD | -11.19% |
| 2016 FY | 21.78 Million USD | 2.34% |
| 2016 Q4 | 21.78 Million USD | -0.76% |
| 2016 Q3 | 21.94 Million USD | -1.0% |
| 2016 Q2 | 22.16 Million USD | 2.39% |
| 2016 Q1 | 21.65 Million USD | 1.74% |
| 2015 Q4 | 21.28 Million USD | 87.13% |
| 2015 Q3 | 11.37 Million USD | 9.22% |
| 2015 Q2 | 10.41 Million USD | 121.2% |
| 2015 Q1 | 4.7 Million USD | -5.87% |
| 2015 FY | 21.28 Million USD | 325.55% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q4 | 5 Million USD | -0.62% |
| 2014 Q3 | 5.03 Million USD | 0.0% |
| 2014 FY | 5 Million USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2013 Q2 | 5 Million USD | -5.24% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | -100.0% |
| 2013 Q1 | 5.28 Million USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 36.1 Million USD | 58.329% |
| BrainsWay Ltd. | 239 Thousand USD | -6194.561% |
| Cerus Corporation | 59.79 Million USD | 74.841% |
| Envoy Medical, Inc. | 404 Thousand USD | -3623.762% |
| electroCore, Inc. | 537 Thousand USD | -2701.49% |
| Helius Medical Technologies, Inc. | 12 Thousand USD | -125266.667% |
| IceCure Medical Ltd | 376 Thousand USD | -3901.064% |
| Inogen, Inc. | 18.27 Million USD | 17.657% |
| OrthoPediatrics Corp. | 13.45 Million USD | -11.777% |
| Lucid Diagnostics Inc. | 199 Thousand USD | -7459.799% |
| Monogram Orthopaedics, Inc. | 363.72 Thousand USD | -4036.103% |
| MaxCyte, Inc. | 17.96 Million USD | 16.278% |
| NeuroOne Medical Technologies Corporation | 55.28 Thousand USD | -27112.213% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| Orthofix Medical Inc. | 93.1 Million USD | 83.842% |
| PAVmed Inc | 2.96 Million USD | -408.243% |
| Rapid Micro Biosystems, Inc. | 6.21 Million USD | -142.098% |
| RxSight, Inc. | 1.21 Million USD | -1142.279% |
| Sight Sciences, Inc. | 31.7 Million USD | 52.555% |
| SI-BONE, Inc. | 36.06 Million USD | 58.286% |
| TELA Bio, Inc. | 40.51 Million USD | 62.868% |
| Treace Medical Concepts, Inc. | 53 Million USD | 71.619% |
| Vivos Therapeutics, Inc. | 1.52 Million USD | -889.086% |
| Acutus Medical, Inc. | 32.65 Million USD | 53.929% |
| Talis Biomedical Corporation | 16.78 Million USD | 10.378% |
| Spectral AI, Inc. | - USD | -Infinity% |
| Nano-X Imaging Ltd. | 4.04 Million USD | -271.916% |
| CVRx, Inc. | 30.38 Million USD | 50.484% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 1.01 Million USD | -1379.355% |
| Bioventus Inc. | 366.99 Million USD | 95.901% |
| Venus Concept Inc. | 70.79 Million USD | 78.748% |
| TriSalus Life Sciences, Inc. | 1.24 Million USD | -1109.325% |
| LivaNova PLC | 568.54 Million USD | 97.354% |
| 908 Devices Inc. | 3.92 Million USD | -282.896% |
| Alphatec Holdings, Inc. | 511.03 Million USD | 97.056% |
| Nemaura Medical Inc. | 3.08 Million USD | -387.231% |
| NeuroPace, Inc. | 56.95 Million USD | 73.586% |
| LENSAR, Inc. | 1.75 Million USD | -759.657% |
| Apyx Medical Corporation | 33.18 Million USD | 54.666% |
| Cutera, Inc. | 418.69 Million USD | 96.407% |
| BioSig Technologies, Inc. | 103 Thousand USD | -14505.825% |
| Anika Therapeutics, Inc. | 26.9 Million USD | 44.083% |
| ClearPoint Neuro, Inc. | 9.94 Million USD | -51.211% |
| Integra LifeSciences Holdings Corporation | 1.48 Billion USD | 98.987% |
| Axonics, Inc. | 25.84 Million USD | 41.78% |
| Outset Medical, Inc. | 134.59 Million USD | 88.823% |
| IRIDEX Corporation | 1.75 Million USD | -759.166% |
| PROCEPT BioRobotics Corporation | 51.33 Million USD | 70.697% |
| IRadimed Corporation | 1.61 Million USD | -831.471% |
| Tivic Health Systems, Inc. | 176 Thousand USD | -8447.727% |
| INVO Bioscience, Inc. | 6.77 Million USD | -122.016% |
| Telesis Bio, Inc. | 5.26 Million USD | -185.519% |
| Viemed Healthcare, Inc. | 5.97 Million USD | -151.939% |
| Varex Imaging Corporation | 464.2 Million USD | 96.759% |
| Quipt Home Medical Corp. | 60.82 Million USD | 75.265% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -2458.503% |
| Pulmonx Corporation | 35.08 Million USD | 57.126% |
| Dynatronics Corporation | 3.25 Million USD | -361.688% |
| Modular Medical, Inc. | 817 Thousand USD | -1741.371% |
| ReShape Lifesciences Inc. | 151 Thousand USD | -9862.914% |
| Semler Scientific, Inc. | 70 Thousand USD | -21391.429% |
| InMode Ltd. | 6.61 Million USD | -127.491% |
| Bruker Corporation | 1.14 Billion USD | 98.686% |
| Cytosorbents Corporation | 2.54 Million USD | -491.618% |
| DexCom, Inc. | 2.57 Billion USD | 99.415% |
| Align Technology, Inc. | 96.96 Million USD | 84.486% |
| Viveve Medical, Inc. | 5.12 Million USD | -193.599% |
| ZimVie Inc. | 508.79 Million USD | 97.043% |
| Movano Inc. | 15.00 USD | -100293233.333% |
| Cytek Biosciences, Inc. | 18.12 Million USD | 16.999% |
| Nexalin Technology, Inc. | - USD | -Infinity% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 398.6 Million USD | 96.226% |
| Profound Medical Corp. | 4.97 Million USD | -202.427% |
| Insulet Corporation | 1.36 Billion USD | 98.899% |
| enVVeno Medical Corporation | 1.06 Million USD | -1313.91% |
| Surmodics, Inc. | 29.4 Million USD | 48.839% |
| iCAD, Inc. | 273 Thousand USD | -5410.623% |
| Nuwellis, Inc. | 221 Thousand USD | -6707.24% |
| Biotricity, Inc. | 10.85 Million USD | -38.58% |
| iRhythm Technologies, Inc. | 34.95 Million USD | 56.956% |
| Aethlon Medical, Inc. | 649.75 Thousand USD | -2215.348% |
| InspireMD, Inc. | 1.03 Million USD | -1349.326% |
| PAVmed Inc. | 2.96 Million USD | -408.243% |
| BIOLASE, Inc. | 13.98 Million USD | -7.572% |
| Beyond Air, Inc. | 14.72 Million USD | -2.194% |
| FONAR Corporation | 37.92 Million USD | 60.337% |
| AxoGen, Inc. | 46.6 Million USD | 67.719% |
| Vivani Medical, Inc. | 19.31 Million USD | 22.104% |
| Tactile Systems Technology, Inc. | 44.61 Million USD | 66.278% |
| Inari Medical, Inc. | 30.35 Million USD | 50.44% |
| UFP Technologies, Inc. | 28 Million USD | 46.271% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 434.04 Thousand USD | -3366.0% |
| Tenon Medical, Inc. | 428 Thousand USD | -3414.953% |
| Autonomix Medical, Inc. Common Stock | 1 Million USD | -1401.397% |
| Co-Diagnostics, Inc. | 2.15 Million USD | -599.012% |
| AdaptHealth Corp. | 2.09 Billion USD | 99.282% |
| Sintx Technologies, Inc. | 3.68 Million USD | -308.028% |
| NanoVibronix, Inc. | - USD | -Infinity% |
| Quanterix Corporation | 37.22 Million USD | 59.584% |
| Inspira Technologies Oxy B.H.N. Ltd. | 588 Thousand USD | -2458.503% |
| Sensus Healthcare, Inc. | 596 Thousand USD | -2424.161% |
| Pacific Biosciences of California, Inc. | 892.24 Million USD | 98.314% |
| TransMedics Group, Inc. | 506.2 Million USD | 97.028% |
| ReWalk Robotics Ltd. | 607 Thousand USD | -2378.418% |
| NeuroMetrix, Inc. | 92.48 Thousand USD | -16166.422% |
| Hyperfine, Inc. | 64 Thousand USD | -23406.25% |
| Establishment Labs Holdings Inc. | 188.73 Million USD | 92.029% |
| Biomerica, Inc. | 459 Thousand USD | -3177.56% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -3246.956% |
| Bluejay Diagnostics, Inc. | 189.98 Thousand USD | -7818.437% |
| Silk Road Medical, Inc | 75.62 Million USD | 80.107% |